Vol 3 (January 2019): Biotarget

Editorial 
What’s up with MALAT1?
Gary A. Clawson
Biotarget  
2019;
3:
3  
Editorial 
The new role of lncRNA MALAT1 as a tumor suppressor
Manuel Regouc, Martin Pichler
Biotarget  
2019;
3:
2  
Editorial 
Engineered natural killer cells expressing chimeric antigen receptors (CAR)—a promising approach in tumor immunotherapy
Brigitte Neuber, Michael Schmitt
Biotarget  
2019;
3:
1